Ticker >

Vaxfab Enterprise share price

Vaxfab Enterprises Ltd.

BSE: 542803 SECTOR: Trading  5096   6   0

11.00
+0.20 (1.85%)
BSE: 26 Apr 04:01 PM

Price Summary

Today's High

₹ 11.01

Today's Low

₹ 10.99

52 Week High

₹ 24.8

52 Week Low

₹ 8.85

FinStar is Suspended!

FinStar can not be assigned to this company due to its dicey outlook and insufficient data. We will update the FinStar for this company as soon as the data is updated from its end.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

9.24 Cr.

Enterprise Value

5.39 Cr.

No. of Shares

0.84 Cr.

P/E

0

P/B

0.76

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  14.56

CASH

4.19 Cr.

DEBT

0.34 Cr.

Promoter Holding

0 %

EPS (TTM)

₹  -4.72

Sales Growth

6045.63%

ROE

3.52 %

ROCE

4.56%

Profit Growth

0 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year6045.63%
3 Year446.42%
5 Year68.72%

Profit Growth

1 Year13276%
3 Year209.02%
5 Year72.46%

ROE%

1 Year3.52%
3 Year1.06%
5 Year0.8%

ROCE %

1 Year4.56%
3 Year1.43%
5 Year1.09%

Debt/Equity

0.0207

Price to Cash Flow

5.12

Interest Cover Ratio

110.80487804878

CFO/PAT (5 Yr. Avg.)

5.19936450660201

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Mar 2024 0 0
Dec 2023 0 0
Sep 2023 0 0
Jun 2023 0.11 0
Mar 2023 0.11 0
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good revenue growth of 446.42203051485% for the Past 3 years.
  • Company is virtually debt free.
  • The company has an efficient Cash Conversion Cycle of -5.77024326941751 days.

 Limitations

  • Company has a poor ROE of 1.05696247359834% over the past 3 years.
  • Company has a poor ROCE of 1.42963000665791% over the past 3 years
  • The company has a low EBITDA margin of -19.1081288872416% over the past 5 years.
  • The company is trading at a high PE of 0.

Quarterly Result (All Figures in Cr.)

PARTICULARS Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
Net Sales 2.03 14.33 4.15 1.9 1.9
Total Expenditure 1.89 14.03 3.89 1.88 6.24
Operating Profit 0.14 0.3 0.26 0.03 -4.33
Other Income 0 0 0 0.12 -0.12
Interest 0 0 0 0 0
Depreciation 0 0 0.01 0.01 0.01
Exceptional Items 0 0 0 0 0
Profit Before Tax 0.14 0.3 0.25 0.13 -4.46
Tax 0.04 0.08 0.06 0.03 0.01
Profit After Tax 0.1 0.22 0.19 0.1 -4.47
Adjusted EPS (Rs) 0.43 0.27 0.22 0.12 -5.33

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Net Sales 0.34 0.1 1.14 0.27 16.75
Total Expenditure 0.33 0.17 1.21 0.36 16.29
Operating Profit 0 -0.06 -0.07 -0.09 0.46
Other Income 0.05 0.06 0.07 0.1 0
Interest 0 0 0 0 0
Depreciation 0.01 0.01 0.01 0.01 0.01
Exceptional Items 0 0 0 0 0
Profit Before Tax 0.05 -0.01 -0.01 0 0.45
Tax 0.01 0 0 0 0.12
Net Profit 0.04 -0.01 -0.01 0 0.33
Adjusted EPS (Rs.) 0.15 -0.05 -0.05 0.01 0.4

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Equity and Liabilities
Share Capital 1.46 1.46 1.46 1.46 8.66
Total Reserves 1.69 1.67 1.66 1.66 7.76
Borrowings 0 0 0 0 0
Other N/C liabilities 0 0 0 0 0
Current liabilities 0.14 0.3 0.09 0.03 10.11
Total Liabilities 3.28 3.43 3.21 3.15 26.52
Assets
Net Block 0.1 0.09 0.08 0.08 0.07
Capital WIP 0 0 0 0 0
Intangible WIP 0 0 0 0 0
Investments 0.12 0.89 0.12 0.12 12.11
Loans & Advances 1.78 1.42 1.31 1.08 0
Other N/C Assets 0.26 0.26 0 0 0
Current Assets 1.02 0.77 1.7 1.87 14.35
Total Assets 3.28 3.43 3.21 3.15 26.52
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Profit from operations 0.05 -0.01 -0.01 0 0.45
Adjustment 0.01 0.01 0.01 0.01 0.01
Changes in Assets & Liabilities 0.95 0.38 -1.21 -0.17 1.37
Tax Paid -0.01 0 0 0 -0.02
Operating Cash Flow 0.99 0.38 -1.21 -0.16 1.8
Investing Cash Flow 0.03 -0.77 0.77 0 -11.99
Financing Cash Flow -1.02 0.36 0.44 0.18 14.36
Net Cash Flow 0 -0.03 0 0.02 4.17

Corporate Actions

Investors Details

PARTICULARS Jun 2022% Sep 2022% Dec 2022% Mar 2023% Jun 2023%
promoters 0.78 0.78 0.78 0.11 0.11
saurabh tapuriah 0.78 0.78 0.78 0.11 0.11
PARTICULARS Mar 2023% Jun 2023% Sep 2023% Dec 2023% Mar 2024%
investors 99.89 99.89 100.00 100.00 100.00
ashokbhai madhubhai korat... 8.90 10.37 3.76 2.19 2.77
bhati shani 11.53 12.12 5.24 5.02 3.58
devi singh - 1.23 1.23 1.23 1.23
hitesh surendrakumar loon... 3.02 3.02 3.02 3.02 3.02
jaimin kailash gupta 9.77 9.77 9.77 9.77 1.60
kabra priya - - 1.90 - 3.10
kaushalkumar chaturbhai s... 1.14 1.14 1.11 1.11 1.11
kresha kailash gupta 6.62 6.62 6.62 6.62 6.62
krishna awtar jagannath k... - - - - 2.86
krishna awtar kabra - - - 4.88 4.88
mayur d patel - - - - 1.70
qmin industries - - - - 8.30
sanjay karanraj sakaria - 1.10 1.00 1.60 1.83
sejal tarakbhai agrawal 3.15 3.15 1.23 1.23 1.23
vax enterprise 9.98 9.98 - 9.98 9.79
veena rajesh shah - - - 1.67 2.08
nilam rajkumar dhandaria - - 2.38 2.38 -
pratit nayan patel - - 1.31 1.31 -
qmin pharma 8.30 8.30 - 8.30 -
sarojdevi s kabra - - 3.27 3.27 -
qmin pharma private limit... - - 8.30 - -
santosh kumar agarwal - - 2.34 - -
uma agarwal - - 2.58 - -
vax enterprise private li... - - 9.98 - -
ila sunil trivedi 1.17 1.07 - - -
multiplier share & stock ... 3.70 2.98 - - -
pooja priyam shah 1.22 1.22 - - -
parth infin brokers (p) l... 1.60 - - - -
vishala hitesh loonia 1.33 - - - -

Annual Reports

Ratings & Research Reports

No Credit and Research reports exist for this company.Report us

Company Presentations

Currently we do not have any Presentation and Concall related to this company.Report us

Company News

Vaxfab Enterprises informs about certificate22 Apr 2024, 2:40PM Vaxfab Enterprise - Quaterly Results7 Feb 2024, 5:04PM Vaxfab Enterprise - Quaterly Results7 Feb 2024, 5:04PM Vaxfab Enterprise - Quaterly Results7 Feb 2024, 5:04PM Vaxfab Enterprises informs about disclosure1 Jan 2024, 4:53PM Vaxfab Enterprises informs about newspaper publication8 Aug 2023, 4:30PM Vaxfab Enterprise - Quaterly Results5 Aug 2023, 6:52PM Vaxfab Enterprise - Quaterly Results5 Aug 2023, 6:52PM Vaxfab Enterprise - Quaterly Results5 Aug 2023, 6:52PM Vaxfab Enterprises informs about disclosure 19 Jul 2023, 11:50AM Vaxfab Enterprises informs about disclosure 19 Jul 2023, 11:45AM Vaxfab Enterprises informs about disclosure 17 Jul 2023, 4:03PM Vaxfab Enterprise - Quaterly Results2 May 2023, 6:52PM Vaxfab Enterprise - Quaterly Results2 May 2023, 6:52PM Vaxfab Enterprises informs about closure of trading window27 Mar 2023, 4:44PM Vaxfab Enterprises informs about non-applicability of large entity framework6 Mar 2023, 4:58PM Vaxfab Enterprises informs about disclosure 3 Mar 2023, 2:24PM Vaxfab Enterprises informs about disclosure 3 Mar 2023, 12:45PM Vaxfab Enterprises informs about disclosure 2 Mar 2023, 11:17AM Vaxfab Enterprises informs about disclosure 2 Mar 2023, 11:12AM Vaxfab Enterprises informs about disclosure1 Mar 2023, 3:25PM Vaxfab Enterprises acquires stake in Vaxtex Cotfab22 Feb 2023, 10:23AM Vaxfab Enterprises informs about disclosure 21 Feb 2023, 5:00PM Vaxfab Enterprises informs about disclosure8 Feb 2023, 3:33PM Ellora Trading informs about outcome of board meeting 12 Jan 2023, 9:45AM Vaxfab Enterprise - Quaterly Results11 Jan 2023, 7:18PM Vaxfab Enterprise - Quaterly Results11 Jan 2023, 7:18PM Vaxfab Enterprise - Quaterly Results11 Jan 2023, 7:18PM Vaxfab Enterprises informs about record date for issuance of equity shares22 Dec 2022, 4:51PM Ellora Trading informs about revised annual report20 Oct 2022, 5:00PM Ellora Trading - Quaterly Results10 Aug 2022, 4:16PM Ellora Trading informs about updates6 Jun 2022, 11:03AM Ellora Trading informs about non- applicability of large corporate entity30 Apr 2022, 2:52PM Ellora Trading informs about non- applicability of large corporate entity23 Apr 2022, 3:12PM Ellora Trading - Quaterly Results21 Apr 2022, 7:12PM Ellora Trading - Quaterly Results21 Apr 2022, 7:12PM Ellora Trading informs about disclosures23 Mar 2022, 4:39PM Ellora Trading informs about financial results19 Nov 2021, 3:33PM Ellora Trading informs about outcome of board meeting18 Nov 2021, 12:29PM Ellora Trading informs about board meeting 8 Nov 2021, 5:17PM Ellora Trading informs about PCS certificate24 Apr 2021, 3:13PM Ellora Trading informs about disclosure17 Apr 2021, 4:01PM Ellora Trading informs about board meeting22 Jun 2020, 4:29PM

Vaxfab Enterprise Stock Price Analysis and Quick Research Report. Is Vaxfab Enterprise an attractive stock to invest in?

 

Stock investing requires careful analysis of financial data to find out the company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement. This can be time-consuming and cumbersome. An easier way to find out about a company's performance is to look at its financial ratios, which can help to make sense of the overwhelming amount of information that can be found in a company's financial statements.

Here are the few indispensable tools that should be a part of every investor’s research process.

  • PE ratio: - Price to Earnings' ratio, which indicates for every rupee of earnings how much an investor is willing to pay for a share. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Vaxfab Enterprise has a PE ratio of -2.33154581487526 which is low and comparatively undervalued .

  • Share Price: - The current share price of Vaxfab Enterprise is Rs 11. One can use valuation calculators of ticker to know if Vaxfab Enterprise share price is undervalued or overvalued.

  • Return on Assets (ROA): - Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Vaxfab Enterprise has ROA of 2.25361984317663 % which is a bad sign for future performance. (higher values are always desirable)

  • Current ratio: - The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Vaxfab Enterprise has a Current ratio of 1.41960574753592 .

  • Return on equity: - ROE measures the ability of a firm to generate profits from its shareholders investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Vaxfab Enterprise has a ROE of 3.51602134426833 % .(higher is better)

  • Debt to equity ratio: - It is a good metric to check out the capital structure along with its performance. Vaxfab Enterprise has a D/E ratio of 0.0207 which means that the company has low proportion of debt in its capital.

  • Inventory turnover ratio: - Inventory Turnover ratio is an activity ratio and is a tool to evaluate the liquidity of a company's inventory. It measures how many times a company has sold and replaced its inventory during a certain period of time. Vaxfab Enterprise has an Inventory turnover ratio of 6.91901044893239 which shows that the management is inefficient in relation to its Inventory and working capital management.

  • Sales growth: - Vaxfab Enterprise has reported revenue growth of 6045.63462949376 % which is fair in relation to its growth and performance.

  • Operating Margin: - This will tell you about the operational efficiency of the company. The operating margin of Vaxfab Enterprise for the current financial year is 2.76487793231063 %.

  • Dividend Yield: - It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Vaxfab Enterprise is Rs 0 and the yield is 0 %.

Last Updated on:
Brief about Vaxfab Enterprise
X